Samuel A Collins

发表

Management of asthma in children with long QT syndrome.

J. Massie, J. Widger, Samuel A Collins, 2012, Paediatric respiratory reviews.

Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.

H. Omran, A. Quittner, C. Kuehni, 2020, The Lancet. Respiratory medicine.

Diagnosis of primary ciliary dyskinesia: potential options for resource-limited countries

P. Goggin, J. Lucas, C. Jackson, 2017, European Respiratory Review.

The dangers of widespread nitric oxide screening for primary ciliary dyskinesia

L. Behan, K. Gove, A. Harris, 2016, Thorax.

Accuracy of diagnostic testing in primary ciliary dyskinesia

P. Lackie, A. Page, E. Adam, 2015, European Respiratory Journal.

Prenatal development is linked to bronchial reactivity: epidemiological and animal model evidence

C. Cooper, H. Inskip, G. Roberts, 2014, Scientific Reports.

ERS Task Force guideline for the diagnosis of primary ciliary dyskinesia

H. Omran, A. Bush, T. Tonia, 2016 .

Identification of early-life risk factor profiles for wheeze phenotypes.

Samuel A Collins, 2014, The Journal of pediatrics.

Infant lung function and wheeze in later childhood in the Southampton Women’s Survey

C. Cooper, H. Inskip, G. Roberts, 2014, European Respiratory Journal.

HHIP, HDAC4, NCR3 and RARB polymorphisms affect fetal, childhood and adult lung function

H. Inskip, G. Roberts, K. Godfrey, 2013, European Respiratory Journal.

European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia

H. Omran, A. Bush, T. Tonia, 2017, European Respiratory Journal.

Cephalosporin-3′-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms

S. Faust, M. Feelisch, G. Connett, 2016, Antimicrobial Agents and Chemotherapy.